Vaccine capacity in the UK
Annual seasonal influenza outbreaks and pandemic disease planning have generated parliamentary interest about the UK's position in sourcing adequate quantities of vaccines. A key policy issue concerns the extent to which the government should stimulate vaccine research and manufacturing capacity rather than it being led by the commercial interests of the pharmaceutical sector. This POSTnote gives an overview of the position in the UK and how public health interests are reconciled with those of industry.
Short title:
Vaccine capacity
Start date:
End date:
Project leader:
Parliamentary Office of Science and Technology of the UK Parliament (POST)
United Kingdom of Great Britain & Northern Ireland